Stock Region Penny Picks
Your Stock Region Penny Picks Watchlist Update 🚀 | Thursday, June 12, 2025.
Your Stock Region Penny Picks Watchlist Update 🚀 | Thursday, June 12, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
⚠️ Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Always do your own research before making investment decisions.
🔥 This Week’s Top Moves
1️⃣ $VTAK - LockeT Sales Skyrocket
Hold onto your hats! $VTAK reported a staggering 200% increase in Q2 2025 sales for their LockeT product, leaving last year's Q2 numbers in the dust. This kind of growth is rare and exciting, signaling massive demand for their tech. Could this be a game-changer for $VTAK? We think so!
2️⃣ $NEHC - New Era Helium’s AI Push
New Era Helium ($NEHC) is advancing hyperscaler discussions while gearing up for a board overhaul. Why care? This pivot to AI infrastructure in the Permian Basin could position them as a key player in a booming industry, blending energy and intelligence. Certainly one to watch as these plans unfold.
3️⃣ $NIVF - Betting Big on UAE Real Estate
$NIVF isn’t playing small. They’re dropping $45 million into the UAE real estate market. It’s an ambitious move, but also one that could bring fruitful returns given the region’s growing property demand. Risky? Sure. Potential for big rewards? Absolutely.
4️⃣ $IXHL - Cleaning House on Warrants
Kudos to $IXHL for canceling all outstanding Series A warrants after a solid ATM execution strategy. It’s a clean slate moment that could simplify their structure and possibly drive investor confidence. Smart move? We think so.
5️⃣ $PLRZ - Advancing CNS Therapeutics
Big news from Polyrizon ($PLRZ)! Their intranasal hydrogel shows promising results for CNS therapeutics. This could revolutionize treatment delivery methods. Science-savvy investors, keep an eye here.
6️⃣ $SOAR - Volato and M2i Tie the Knot
$SOAR announced a strategic combo with M2i Global. The partnership aims to create industrial scale and platform independence, unlocking a treasure chest of possibilities. Could this be their ticket to soaring heights?
7️⃣ $SINT - Strategic Expansion Vision
SINTX Technologies ($SINT) revealed plans for expansion across multiple key sectors. Broad moves like these can be risky, but if executed well, might open up fresh revenue avenues. Worth monitoring.
8️⃣ $RSLS - Tapping into VA and DoD Markets
Big win for ReShape Lifesciences ($RSLS)! Their exclusive deal with Recon Supply connects them directly with VA and DoD markets. This means access to consistent and potentially high-volume clients. A noteworthy strategic play.
9️⃣ $TDTH - $500M Financing Plan
$TDTH is making waves with a financing plan of up to $500M for XRP Treasury. Appointing Chaince Securities as a strategic advisor adds gravitas to their move. If you’re into blockchain finance, this is a deal worth following.
🔟 $XTIA - Accelerating xVTOL Development
XTI ($XTIA) is collaborating with Oak Ridge National Labs to rev up their xVTOL development using some serious supercomputer power. Tech enthusiasts, this might be one to keep on your radar.
11️⃣ $IPA - AI-Designed Breakthroughs
ImmunoPrecise Antibodies ($IPA) is making waves with their GLP-1 AI-designed peptides outperforming semaglutide. This advancement is thrilling! The intersection of AI and biotechnology continues to amaze.
12️⃣ $HSDT - Positive MS Study Results
$HSDT presented positive results at the MS Centers Annual Meeting. While it’s one step in a longer process, it’s promising progress in treating multiple sclerosis.
13️⃣ $ZDGE - Blowing Past Expectations
Finally, $ZDGE crushed earnings predictions, reporting $0.06 per share versus the expected $0.02. A 200% beat! Sales also edged slightly higher year-over-year. Consistent performance is always a good look.
📩 Stay informed, stay ready, and keep watching.
See you next week,
The Stock Region Team 🚀
⚠️ Disclaimer: All stock performance and business updates are subject to risks and uncertainties. Do not interpret this as financial advice. Please conduct your own research or consult with a financial advisor.